
|Articles|October 1, 2003
Hydrophilic IOL yields low incidence of Nd:YAG capsulotomy
Author(s)Lynda Charters
New York-The 1-year follow-up of the Hydroview IOL (Bausch & Lomb) indicates that the lens is safe and provides excellent postoperative visual outcomes, a low incidence of Nd:YAG capsulotomy, and no cases of decentration, according to Douglas Grayson, MD, FACS.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
3
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
4
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
5





















